Johnson & Johnson (JNJ) Announces Launch of the VIRTUGUIDE™ System
Johnson & Johnson (NYSE:JNJ) is one of the top cheap pharmaceutical stocks to buy now.
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Yacktman Asset Management Donald Yacktman | 1,363,534 | $208,279,757 | -1% | 2.8% |
| 2. | Markel Gayner Asset Management Tom Gayner | 610,800 | $93,299,700 | 0.79% | |
| 3. | Platinum Asset Management Kerr Neilson | 439,508 | $67,134,847 | +1123% | 4.46% |
| 4. | Pzena Investment Management Richard S. Pzena | 246,313 | $37,624,311 | +5% | 0.12% |
| 5. | Levin Capital Strategies John A. Levin | 207,492 | $31,694,403 | -1% | 3.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing | |
| $139.68 | 3,000 | $419,040.00 | 3,000 | 2019-06-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $163.55 | 19,137 | $3,129,829.56 | 10,658 | 2025-07-17 | Filing | |
| $165.88 | 6,999 | $1,160,994.12 | 21,001 | 2025-02-25 | Filing | |
| $156.15 | 403 | $62,928.45 | 15,098 | 2025-02-18 | Filing | |
| $153.89 | 13,015 | $2,002,878.35 | 0 | 2025-02-07 | Filing | |
| $165.06 | 5,635 | $930,113.10 | 18,973 | 2024-08-30 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 60,609,476 | $9,227,987,872 | 0.65% | |
| 2. | 23,802,503 | $3,635,832,348 | 0.69% | |
| 3. | 18,005,603 | $2,750,355,860 | 0.87% | |
| 4. | 7,016,164 | $1,071,718,896 | 2.51% | |
| 5. | 6,342,997 | $968,892,792 | 3.96% |
News See All
11 Cheap Pharmaceutical Stocks to Buy Now
The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the steps they should take to decrease the prices of US prescription drugs to “most...
Johnson & Johnson’s (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock
Johnson & Johnson (NYSE:JNJ) stands out as a financially strong company, being one of only two firms globally with a perfect AAA credit rating, higher than that of the US government.
10 Best Dividend Stocks to Buy for Retirement
Dividend stocks are considered a good option for retirees because they tend to offer stability during difficult market periods.
New Drug, New Direction: J&J Moves Deeper Into Late-Stage Therapeutics
Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New Drug Application to the U.S.
Johnson & Johnson (JNJ) Upgraded to Buy as Growth and Margins Impress Analysts
Johnson & Johnson (NYSE:JNJ) ranks among the stocks to benefit from an onshoring boom. On July 23, Erste Group raised the stock rating of Johnson & Johnson (NYSE:JNJ) from Hold to Buy.
Guggenheim Lifts PT on Johnson & Johnson (JNJ) to $167 From $164, Keeps a Neutral Rating
Johnson & Johnson (NYSE:JNJ) is one of the top low volatility healthcare stocks to buy now.
10 Best Trade-War-Resistant Stocks to Buy
There’s a particular tension that ripples through markets when growth cools but costs don’t, like a car trying to coast with the parking brake still on. The U.S.
Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target
Johnson & Johnson (NYSE:JNJ) ranks among the best low volatility stocks to buy according to analysts.